TISSUE REGENIX GROUP is a pioneering, international medical technology company, focusing on the development of regenerative products utilising our two platform technologies, dCELL®, addressing soft tissue needs, and BioRinseTM, providing inductive bone allografts.
We are helping to transform the treatment of patients in three key areas: BioSurgery, Orthopaedics & Dental and Cardiac.
Director Interviews
Tissue Regenix increasing throughput in its facility to meet 'exceptional demand' for its products
Director Interviews
Full interview: Tissue Regenix to boost production capacity as its sees strong global demand for its products
